Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Chamaeleo Pharma Names Han Van ‘t Klooster VP of Commercial Operations | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Chamaeleo Pharma Names Han Van ‘t Klooster VP of Commercial Operations

Will lead Fosfestrol product initiatives

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Chamaeleo Pharma NV, a Belgium-based oncology company, has named Han Van ‘t Klooster as vice president of commercial operations. He will be a member of Chamaeleo’s management team and will be responsible for the market access and commercial launch of the company’s lead product Fosfestrol for the treatment of advanced prostate cancer.

Mr. Van ‘t Klooster has over 20 years of business experience in the pharmaceutical industry. Prior to joining Chamaeleo, he was the general manager of Pharmion Europe, acquired by Celgene. Before Pharmion, he was the international marketing director oncology at Chiron Corporation—acquired by Novartis—where he was responsible for the commercialization of two oncology products. Mr. Van ‘t Klooster started his career at AstraZeneca as a product manager.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters